01 July 2021
A new article in press in the Journal of the European Academy of Dermatology and Venereology reveals that nearly half (43%) of the respondents to the PsoProtectMe survey reported worsening of psoriasis during the pandemic. Moreover, a greater proportion of those reporting worsening psoriasis had signs of anxiety or depression (47%) compared to those without worsening psoriasis (29%).
These findings confirm that, now more than ever, access to psychological support is fundamental to safeguard the mental and physical health of people living with psoriasis. This information is precious for advocacy work, as IFPA has always advocated for mental health services to become part of a holistic, person-centered model of care for psoriasis. Mental health support is far from being the norm in psoriasis care, therefore it should be implemented where not currently available and, as shown by this recent article, be maintained in times of emergencies such as the current COVID-19 pandemic.
IFPA’s involvement in research projects such as PsoProtectMe ensures that important scientific findings are translated into advocacy action to improve psoriasis care. This is why IFPA will continue supporting research efforts by partnering with relevant entities, to the benefit of all people living with psoriatic disease.
Facts from the article